Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Equillium Inc EQ

Equillium, Inc. is a clinical-stage biotechnology company. It is engaged in developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The Company’s pipeline consists of immunomodulatory assets and a product platform targeting immuno-inflammatory pathways. The Company’s EQ101 is a selective tri-specific cytokine inhibitor targeting IL-2, IL... see more

NDAQ:EQ - Post Discussion

Equillium Inc > Bang zoom
View:
Post by happerdan on Jul 13, 2020 3:33pm

Bang zoom

To the moon!
Comment by GassXX on May 29, 2022 5:13am
Comment by Joe455 on May 30, 2022 12:35pm
Those T cells can be tricky.
Comment by Lisagerrard17 on Jul 08, 2022 8:57am
Comment by SusanBolland on Jul 11, 2022 5:53am
Comment by SamCanar on Aug 01, 2022 5:24am
This post has been removed in accordance with Community Policy
Comment by JohnTool321 on Aug 05, 2022 7:58pm
Comment by MollyJohn on Oct 18, 2022 9:58am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities